Literature DB >> 8825046

Haplotype analysis in prenatal diagnosis and carrier identification of Salla disease.

J Schleutker1, P Sistonen, P Aula.   

Abstract

Salla disease (SD) is an autosomal recessive disorder in which free sialic acid (N-acetyl neuraminic acid) accumulates in lysosomes. A specific transport mechanism for acidic monosaccharides on the lysosomal membrane has recently been described, but the molecular deficiency causing SD is still unknown. We have previously mapped the SD gene to 6q14-q15 by means of genetic linkage analysis and restricted the positive chromosomal area to less than 100 kb with linkage disequilibrium mapping. The two best allelic association markers have now retrospectively been used in five prenatal analyses originally studied with sialic acid assays in chorionic villus specimens. In four cases an unaffected fetus was predicted with a probability level of more than 94%, which was in concordance with the biochemical data. One fetus was predicted to be affected with over 96% probability, as was shown by free sialic acid assays in a CVS sample and in fetal tissues after termination of the pregnancy. Risk calculations incorporating disequilibrium were also used to predict the carrier status in members of six families with previous SD cases, and also in a few cases with no known family history of SD. DNA marker based analysis thus provides a reliable method for risk estimations in prenatal cases and for carrier identification of SD.

Entities:  

Mesh:

Year:  1996        PMID: 8825046      PMCID: PMC1051809          DOI: 10.1136/jmg.33.1.36

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  22 in total

1.  Southern blot analysis of DNA extracted from formalin-fixed pathology specimens.

Authors:  L Dubeau; L A Chandler; J R Gralow; P W Nichols; P A Jones
Journal:  Cancer Res       Date:  1986-06       Impact factor: 12.701

2.  Prenatal diagnosis and confirmation of infantile sialic acid storage disease.

Authors:  E Vamos; J Libert; N Elkhazen; E Jauniaux; J Hustin; P Wilkin; J Baumkötter; K Mendla; M Cantz; G Strecker
Journal:  Prenat Diagn       Date:  1986 Nov-Dec       Impact factor: 3.050

3.  Defective sialic acid egress from isolated fibroblast lysosomes of patients with Salla disease.

Authors:  M Renlund; F Tietze; W A Gahl
Journal:  Science       Date:  1986-05-09       Impact factor: 47.728

4.  "Salla disease": a new lysosomal storage disorder.

Authors:  P Aula; S Autio; K O Raivio; J Rapola; C J Thodén; S L Koskela; I Yamashina
Journal:  Arch Neurol       Date:  1979-02

5.  Linkage disequilibrium utilized to establish a refined genetic position of the Salla disease locus on 6q14-q15.

Authors:  J Schleutker; A P Laine; L Haataja; M Renlund; J Weissenbach; P Aula; L Peltonen
Journal:  Genomics       Date:  1995-05-20       Impact factor: 5.736

6.  Clinical and laboratory diagnosis of Salla disease in infancy and childhood.

Authors:  M Renlund
Journal:  J Pediatr       Date:  1984-02       Impact factor: 4.406

7.  Infantile form of sialic acid storage disorder: clinical, ultrastructural, and biochemical studies in two siblings.

Authors:  M Tondeur; J Libert; E Vamos; F Van Hoof; G H Thomas; G Strecker
Journal:  Eur J Pediatr       Date:  1982-10       Impact factor: 3.183

8.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

9.  Screening of inherited oligosaccharidurias among mentally retarded patients in northern Finland.

Authors:  P Aula; M Renlund; K O Raivio; S L Koskela
Journal:  J Ment Defic Res       Date:  1986-12

10.  Salla disease in one non-Finnish patient.

Authors:  B Echenne; M Vidal; I Maire; J C Michalski; P Baldet; J Astruc
Journal:  Eur J Pediatr       Date:  1986-09       Impact factor: 3.183

View more
  1 in total

Review 1.  Lysosomal transport disorders.

Authors:  G M Mancini; A C Havelaar; F W Verheijen
Journal:  J Inherit Metab Dis       Date:  2000-05       Impact factor: 4.982

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.